| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.34 | 0.04 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.26 | 0.04 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |